Pazinib 400mg Tablet
Marketer
Hetero Healthcare Limited
Salt Composition
Pazopanib (400mg)
Overview Pazinib 400mg Tablet
For kidney and soft tissue cancers, Pazinib 400mg tablets, a protein kinase inhibitor, are prescribed. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can lead to severe adverse reactions. While therapeutic effects may take weeks or months to manifest, discontinue only as directed. Common side effects include elevated blood pressure and diarrhea; the former warrants regular monitoring, while the latter is often managed with increased fluid intake, though you should consult your doctor if it's persistent. Pazinib can lower blood cell counts, increasing infection risk; report fever, flu-like symptoms, or breathlessness immediately. Prior to commencing treatment, disclose any heart, liver, or kidney conditions, or concurrent use of infection-fighting medications. Inform your healthcare provider of all medications you are taking, as interactions are possible. Pazinib is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Pazinib 400mg Tablet
No information provided. Unable to rephrase.
Uses of Pazinib 400mg Tablet
Renal cell carcinoma and soft tissue sarcoma
Major Benefits of Pazinib 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 400mg Pazinib tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Pazinib 400mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazinib 400mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 400mg Pazinib tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Pazinib 400mg Tablet works:
Pazinib 400mg tablets are an anticancer drug that targets tyrosine kinase enzyme receptors. By binding to these receptors, it blocks their activity, thereby curbing the growth and spread of malignant cells. Furthermore, Pazinib inhibits angiogenesis, reducing the formation of new blood vessels that supply the tumor. This dual mechanism of action underlies its anti-cancer effect.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazinib 400mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Pazinib 400mg tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and Pazinib 400mg tablets are incompatible; the medication poses a potential risk of infant toxicity.
DrivingUNSAFE
Taking a 400mg Pazinib tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects appear.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Pazinib 400mg tablets are considered safe. No dosage modification is advised for Pazinib 400mg tablets in this population.
LiverCAUTION
Patients with liver impairment should use Pazinib 400mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is recommended. Pazinib 400mg tablets are contraindicated in patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Pazinib 400mg Tablet :
NA
Facts to Know About Pazinib 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Actions | Tyrosine kinase inhibitor drugs |
3,018 People bought this recently